US Drug Recall Register
Class II · Moderate risk Terminated Initiated Feb 9, 2018 (9 years ago)

Verapamil HCl USP for prescription compounding

Class II — Moderate risk. May cause temporary or reversible harm; serious harm unlikely.

Why it was recalled

CGMP Deviations: Lack of stability data and controls to support the manufacturers assigned retest or expiration date in firm's container/closure system.

What was recalled

Verapamil HCl USP for prescription compounding, packaged in a) 100g (NDC 58597-8039-6); b) 500g (NDC 58597-8039-7); c) 1000g (NDC 58597-8039-8), RX only, packed by American Pharmaceutical Ingredients, LLC 6650 Highland Road, Waterford, MI 48327

Recalling firm
American Pharmaceutical Ingredients LLC
NDC code
58597-8039-6
Origin
MI, United States
Initiated by
Voluntary: Firm initiated
FDA recall number
D-0534-2018

What should you do? A recall doesn't always mean your specific bottle is affected - it often applies to certain lots only. Check the lot number on your package against the FDA notice, and talk to your pharmacist before stopping any medication.

Other Verapamil recalls

See all
Class III · Low risk Ongoing

Verapamil Hydrochloride Injection

Reason Cross contamination with other products.

Zydus Pharmaceuticals (USA) Inc D-0593-2024
Class III · Low risk Ongoing

Verapamil Hydrochloride Injection

Reason Cross contamination with other products.

Zydus Pharmaceuticals (USA) Inc NDC 70710-1643-7 D-0592-2024
Class II · Moderate risk Terminated

Verapamil Hydrochloride Extended-Release Tablets

Reason Failed Dissolution Specifications: Out of specification dissolution results above specified values.

Amerisource Health Services LLC D-0536-2023
Class II · Moderate risk Terminated

Verapamil Hydrochloride Extended-Release Tablets

Reason Failed Dissolution Specification: Out of specification dissolution results at time point zero. The OOS was above specified values.

Amerisource Health Services LLC D-0436-2023